Results 91 to 100 of about 45,062 (281)

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

Advanced NanoBiomed Research, Volume 5, Issue 12, December 2025.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez, Julio García‐Cordero, Gabriela Navarro‐Tovar, Leticia Cedillo‐Barrón   +3 more
wiley   +1 more source

Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination. [PDF]

PLoS Neglected Tropical Diseases, 2010
A new commercial anti-Japanese encephalitis virus IgM and IgG indirect immunofluorescence test (IIFT) was evaluated for the detection of the humoral immune response after Japanese encephalitis vaccination.
Nadine Litzba, Christoph S Klade, Sabine Lederer, Matthias Niedrig   +3 more
doaj   +1 more source

Infant Botulism: A Case Study in Integrated Clinical and Public Health Response

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Early recognition of constipation, feeding difficulty, and descending weakness in infants is vital for prompt diagnosis of infant botulism. Bedside nerve studies support early treatment. Rapid public health notification and coordinated access to specific therapies, including timely use of BAT and BIG‐IV, are essential to optimize outcomes and ...
John Gannon, Tiarnán Fallon Verbruggen, Sinéad Burke, Leah Loughlin, Cally Brits, Kara Tedford, John C. McHugh, Huw Mayberry, Mary O'Regan, Bridget Freyne, Niall Conroy   +10 more
wiley   +1 more source

Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. [PDF]

, 2017
OBJECTIVE: To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance.
Clark, Andrew, Clark, Samantha, Ferrari, Matthew, Franklin, Heather, Friberg, Ingrid K, Garske, Tini, Goldie, Sue J, Grewal, Simrun, Hansen, Peter M, Johnson, Hope L, Li, Michelle, Mirelman, Andrew, Ozawa, Sachiko, Portnoy, Allison, Sinha, Anushua, Stack, Meghan L, Suraratdecha, Chutima, Sweet, Steven, Tam, Yvonne, Walker, Damian, Walker, Neff   +20 more
core   +4 more sources

Clinical progress note: Varicella Zoster

Journal of Hospital Medicine, Volume 20, Issue 12, Page 1348-1350, December 2025.
Abstract Varicella Zoster virus (VZV) is the etiologic agent responsible for varicella and herpes zoster (shingles). Nonimmune children and adults acutely infected with VZV typically experience a vesicular and pruritic rash that progresses from the face and trunk and generalizes to the extremities, accompanied by an oral enanthem along with symptoms of
Sirey Zhang, Adam L. Hersh, T. W. Jones
wiley   +1 more source

Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine

, 2013
This investigation evaluated several factors associated with diverse participant enrollment of a clinical trial assessing safety, immunogenicity, and comparative viremia associated with administration of 17-D live, attenuated yellow fever vaccine given ...
Edupuganti, Srilatha, Frew, Paula M., Keyserling, Harry L., Lu, Lu, Mulligan, Mark J., Shapiro, Eve T.   +5 more
core   +1 more source

Systematic Review of Postvaccination Ocular Adverse Events: A Comprehensive Analysis of Published Reports

Journal of Medical Virology, Volume 97, Issue 12, December 2025.
ABSTRACT Ocular adverse events following COVID‐19 vaccination are well described; however, systematic analyses of non‐COVID antiviral vaccines remain limited. This review aimed to evaluate ocular complications associated with non‐COVID antiviral immunizations, including influenza, varicella‐zoster (VZV), human papillomavirus (HPV), and hepatitis B (HBV)
Yaru Zou, Koju Kamoi, Yuan Zong, Jing Zhang, Mingming Yang, Kyoko Ohno‐Matsui   +5 more
wiley   +1 more source

Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review

Frontiers in Immunology
Vaccination remains the sole effective strategy for combating Japanese encephalitis (JE). Both inactivated and live attenuated vaccines exhibit robust immunogenicity. However, the production of these conventional vaccine modalities necessitates extensive
Takele Adugna, Takele Adugna, Takele Adugna, Qingli Niu, Qingli Niu, Guiquan Guan, Guiquan Guan, Junzheng Du, Junzheng Du, Jifei Yang, Jifei Yang, Zhancheng Tian, Zhancheng Tian, Hong Yin, Hong Yin   +14 more
doaj   +1 more source

Japanese Encephalitis Immunization in South Korea: Past, Present, and Future

Emerging Infectious Diseases, 2000
Japanese encephalitis (JE), once a major public health problem in South Korea, has declined since the 1980s, as a result of improved living conditions, a mosquito eradication program, and a national JE vaccination program, which includes annual booster ...
Young Mo Sohn
doaj   +1 more source

Polyethylene Glycol‐Functionalized Graphene Oxide Nanocomposites: Advances in Biomedical Applications

Nano Select, Volume 6, Issue 12, December 2025.
Polyethylene glycol‐functionalized graphene oxide (PEG‐GO) nanocomposites revolutionize nanomedicine with their high surface area and tunable properties. This review explores their synthesis, characterization, and applications in drug delivery, gene therapy, biosensing, and photothermal therapy.
Oluwasegun Chijioke Adekoya, Gbolahan Joseph Adekoya, Williams Kehinde Kupolati, Yskandar Hamam, Rotimi Emmanuel Sadiku   +4 more
wiley   +1 more source